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Lytic replicationA (LMP2A) of Epstein–Barr virus (EBV) plays a key role in regulating viral latency
and EBV pathogenesis by functionally mimicking signals induced by the B-cell receptor (BCR) altering normal
B cell development. As c-Cbl ubiquitin ligase (E3) is a critical negative regulator in the BCR signal pathway,
the role of c-Cbl in the function and formation of the LMP2A signalosome was examined. c-Cbl promoted
LMP2A degradation through ubiquitination, speciﬁcally degraded the Syk protein tyrosine kinase in the
presence of LMP2A, and inhibited LMP2A induction of the EBV lytic cycle. Our earlier studies indicated that
LMP2A-dependent Lyn degradation was mediated by Nedd4-family E3s in LMP2A expressing cells. Combine
with these new ﬁndings, we propose a model in which c-Cbl and Nedd4-family E3s cooperate to degrade
target proteins at discrete steps in the function of the LMP2A signalosome.
© 2008 Elsevier Inc. All rights reserved.IntroductionLatent membrane protein 2A (LMP2A) is an Epstein–Barr virus
(EBV) encoded protein that has been implicated in regulating viral
latency and pathogenesis in EBV infections (Ikeda et al., 2005;
Longnecker, 2000). LMP2A functions as a signalosome by constitu-
tively associating and activating proteins normally associated with the
B cell receptor (BCR) (Longnecker, 2000). The understanding of the
molecular basis of LMP2A-mediated signaling is essential to clarify the
involvement of LMP2A in EBV latent infections and EBV-related
malignancies. The elucidation of differences between the BCR and
LMP2A signaling may aide the development of novel therapeutic
agents to treat EBV latent infections and EBV-associated cancers.
The LMP2A amino-terminal domain interacts and activates with
the Src family protein tyrosine kinase (PTK) Lyn and the Syk PTK
(Fruehling and Longnecker, 1997; Fruehling et al., 1998; Rovedo and
Longnecker, 2008) in a constitutive manner mimicking a BCR
providing development and survival signals in the absence of
corresponding antigens (Caldwell et al., 1998). In contrast to the
BCR, LMP2A contains two PY motifs (PPXY) that speciﬁcally associate
with Nedd4-family ubiquitin–protein ligases (E3s) resulting in the
downmodulation of LMP2A activity by ubiquitinating both LMP2A and
LMP2A-associated PTKs (Ikeda et al., 2000; Ikeda et al., 2001;Winberg
et al., 2000). In addition, LMP2A ubiquitination negatively regulates
LMP2A signal transduction in B cell development (Ikeda et al., 2003;Longnecker).
l rights reserved.Ikeda et al., 2004). LMP2A ubiquitin-dependent processes are likely
important for LMP2A function in EBV latent infection such as the
modulation of LMP2A-induced signals which alter normal B cell
development (Casola et al., 2004; Ikeda et al., 2004).
BCR stimulation triggers the activation of PTKs, which leads to the
phosphorylation of numerous signal molecules such as adapter,
docking and effecter proteins (Kurosaki, 2002). The phosphorylation
of B cell signal molecules is critical for their recruitment to the plasma
membrane and the formation of BCR signalosome. The proto-
oncogenic protein c-Cbl and other Cbl-family proteins have been
recognized as key players in the negative regulation of antigen
receptor and other signaling pathways (Swaminathan and Tsygankov,
2006). c-Cbl is a RING-ﬁnger E3 that negatively regulates the BCR and
other signal pathways by targeting multiple signal molecules for
degradation. These targets include Src-family and Syk PTKs (Swami-
nathan and Tsygankov, 2006). Cbl proteins are multivalent adapter
proteins capable of interacting with multiple signal components
(Swaminathan and Tsygankov, 2006). The phosphorylation of Cbl
proteins following signal stimulation is essential for the pivotal role of
Cbl proteins for their adaptor function (Swaminathan and Tsygankov,
2006).
Several previous studies have shown that c-Cbl interacts with
known LMP2A-associated proteins. Two Nedd4-family E3s, Nedd4
and AIP4/Itch, bind to three Cbl-family proteins and target them for
degradation, which inhibits Cbl-mediated desensitization of acti-
vated EGFR and non-receptor c-Src PTKs (Courbard et al., 2002;
Magniﬁco et al., 2003). Syk is a target of Cbl-mediated ubiquitina-
tion and degradation upon BCR stimulation (Rao et al., 2001). Cbl
proteins preferentially interact with and target Src-family PTKs
Fig. 1. LMP2A degradation and LMP2A inhibition of EBV lytic replication by c-Cbl. (A)
BJAB, BJAB-LMP2A+, LMP2A-expressing LCLs and LMP2A-deleted LCLs were infected
with c-Cbl shRNAmir or nonesilencing (NS) shRNAmir lentiviruses. Cell lysates were
immunoblotted for c-Cbl and GAPDH. (B) EREB2.5 cells were infected with c-Cbl
shRNAmir or nonesilencing (NS) shRNAmir lentiviruses. Selected cells were depleted
with estrogen and transfected with LMP2A-expressing plasmid or control vector. Cell
lysates were immunoblotted for LMP2A, BZLF1, c-Cbl and GAPDH. (C) BJAB cells were
transfected with 5 μg of reporter plasmid expressing ﬁreﬂy luciferase under the control
of BZLF1 promoter (Zp) with 20 μg of LMP2A and indicated μg of c-Cbl. Average fold
induction of luciferase activity to promoterless plasmid with no activator is indicated.
Data averaged from three independent experiments are shown±standard deviation.
The western blots are representative of three comparable experiments.
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Kaabeche et al., 2004; Rao et al., 2002; Sanjay et al., 2001). These
interactions suggest that c-Cbl may interact with LMP2A-associated
proteins with functional consequences. In addition, c-Cbl is
constitutively phosphorylated in LMP2A-expressing LCLs (Engels et
al., 2001). Taken together, these previous studies suggest c-Cbl
adaptor functions in LMP2A signaling and the downmodulation of
LMP2A signaling by c-Cbl E3 activity. In this paper, we demonstrate
that c-Cbl promotes the degradation of LMP2A and LMP2A
associated proteins. Furthermore, our results indicate that c-Cbl
may be an important regulator of EBV latency by blocking LMP2A-
mediated induction of the EBV lytic cycle as has been previously
observed (Schaadt et al., 2005).
Results
c-Cbl inhibits the expression of LMP2A
To examine whether c-Cbl downmodulates LMP2A-mediated
signaling, c-Cbl speciﬁc shRNA was used to reduce expression of the
c-Cbl protein. LMP2A+ and LMP2A− BJAB cells and EBV infected LCLs
were infected with a lentivirus containing c-Cbl shRNAmir and
transduced cells were selected by puromycin selection. In BJAB cells,
the reduction of c-Cbl protein was at approximately 90% compared
to nonspeciﬁc shRNAmir infected control cells (Fig. 1A, c-Cbl, lanes
1–4) as determined by densitometry. In LMP2A+ and LMP2A− LCLs,
the c-Cbl reduction was approximately 50% (Fig. 1A, c-Cbl, lanes 5–
8) also as determined by densitometry. In both BJAB cells and LCLs
expressing LMP2A there was very modest decrease in LMP2A
expression (Fig. 1A, LMP2A, compare lane 3 with lane 4 and lane 5
with lane 6). The levels of GAPDH were similar in all lysates (Fig. 1A,
GAPDH).
c-Cbl negatively regulates LMP2A-mediated EBV lytic induction
To further examine the c-Cbl role in LMP2A signaling, LMP2A-
mediated EBV lytic induction was examined. It has been reported that
transient expression of LMP2A can induce expression of the EBV
immediate early protein BZLF1 using EREB2.5 cells (Schaadt et al.,
2005). EREB2.5 cells were established by the infection of human B
cells with a recombinant EBV expressing an EBNA2-estrogen receptor
fusion protein (Kempkes et al., 1996). Upon estrogen depletion, EBNA2
is inactivated and EBNA2-dependent genes including LMP2A are
downregulated. In the absence of EBNA2, these cells are highly
permissive for virus reactivation. An LMP2A expressing plasmid was
transiently transfected into freshly estrogen depleted EREB2.5 cells. In
the cells without LMP2A transfection, the basal level of LMP2A
expressed in the EREB2.5 cells was observed (Fig. 1B, LMP2A, lane 1).
As previously reported, overexpression of LMP2A induced EBV lytic
replication over the baseline levels of lytic replication as measured by
BZLF1 (Fig. 1B, BZLF1, lane 2). In c-Cbl shRNAmir lentivirus infected
EREB2.5 cells, c-Cbl silencing induced BZLF1 regardless of LMP2A
transfection (Fig. 1B, BZLF1, lanes 1 and 3). Interestingly, LMP2A
transfection into c-Cbl shRNA cells increased BZLF1 induction to a
greater extent than when compared to LMP2A or c-Cbl shRNA only
cells (Fig. 1B, BZLF1, compare lane 4 with lanes 2 and 3). Finally, we
sought to determine whether LMP2A activates the BZLF1 promoter.
The requited activating region (−221 to +12) of BZLF1 promoter (Zp)
was cloned into the pGL3 Basic reporter vector, rendering expression
of ﬁreﬂy luciferase dependent upon the Zp. BJAB cells were transiently
transfected with the Zp-reporter and the LMP2A expression plasmid.
Expression of LMP2A alone was sufﬁcient to activate the Zp (Fig. 1C).
LMP2A induced an eight-fold increase in the relative luciferase activity
but did not induce luciferase activity from the promoterless pGL3
Basic reporter vector (Fig. 1C). The expression of c-Cbl signiﬁcantly
decreased the fold induction of LMP2A-mediated luciferase activity ina dose-dependent manner indicating that c-Cbl inhibits LMP2A-
mediated BZLF1 induction.
Expression and degradation of LMP2A, Lyn, and Syk in the presence
of c-Cbl
We next examined the molecular mechanism of Cbl-catalyzed
degradation of the LMP2A complex. Expression plasmids for LMP2A,
Lyn, Syk and c-Cbl were co-transfected in B cells and Chinese hamster
ovary (CHO-K1) cells. The level of each protein in cell lysates was
determined by immunoblotting with speciﬁc antibodies. The transient
expression of LMP2A and c-Cbl was readily observed in BJAB and CHO-
K1 cells, whereas signiﬁcant increases of Lyn and Syk was only
observed in the CHO-K1 cells (Fig 2A). Compatible with the c-Cbl
silencing results, c-Cbl caused a decrease in LMP2A expression in the
Fig. 2. Expression and ubiquitination of LMP2A signalosome.(A) BJAB and CHO-K1 cells
were transfected with 10 or 1 μg of LMP2A, Lyn, Syk-Myc and c-Cbl-Flag, respectively.
Cell lysates were immunoblotted with anti-LMP2A, Lyn, Syk or c-Cbl antibody to detect
both endogenous and transfected expression. (B) BJAB cells were transfected with 10 μg
of LMP2A, Ub-HA and c-Cbl-Flag, respectively. LMP2A immunoprecipitates were
immunoblotted with anti-HA antibody to detect ubiquitin-conjugated LMP2A. Cell
lysates were immunoblotted with anti-c-Cbl antibody. The data is the representative of
four comparable experiments.
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with lane 6). c-Cbl also caused LMP2A ubiquitination (Fig. 2B),
indicating that c-Cbl targeted LMP2A to be degraded by the
proteasome. When Lyn and Syk were coexpressed with LMP2A and
c-Cbl, LMP2Awas degraded to a greater extent (Fig. 2A, LMP2A, lanes 3
and 7), indicating that LMP2A-associated signal molecules are critical
for promoting LMP2A degradation. Interestingly, LMP2A caused a
dramatic decrease in Syk in CHO-K1 and even in BJAB cells (Fig. 2A,
Syk, compare lane 3 with lane 4 and lane 7 with lane 8). However,
LMP2A did not alter the level of Lyn (Fig. 2A, Lyn, compare lane 3 with
lane 4 and lane 7 with lane 8). This difference between the ability of
LMP2A to effectively target Lyn in transient transfections when
compared to cells stably expressing LMP2A has previously been
observed (Rovedo and Longnecker, 2008). This indicates that LMP2A
speciﬁcally regulates the degradation of Syk which is a key player in
LMP2A signaling (Merchant et al., 2000).
Since the results obtained with the B cell line were consistent with
the CHO-K1 results, we chose to use this approach to examine the
details of c-Cbl function in LMP2A signaling for their ease of
transfection, the resulting high levels of protein expression, and
reduced levels or lack of expression of Lyn, Syk and Cbl. Similar
approaches using COS, 293T, NIH-3T3 and insect cells have been used
to dissect the molecular mechanisms for a variety of receptors
including the BCR, T cell receptor (TCR), and high afﬁnity IgE receptor(FcɛRI) (Saouaf et al., 1995; Scharenberg et al., 1995; Wossning and
Reth, 2004; Yamamoto et al., 2001). Initially, LMP2A expression was
examined in transfected CHO-K1 cells. Interestingly, a reduction of
LMP2A was always observed when Lyn was coexpressed (Fig. 3A,
LMP2A, compare lanes 9, 10, and 13 with lanes 8, 11, 12, and 14).
However, Syk expression did not change levels of LMP2A (Fig. 3A,
LMP2A). This indicates that Syk is not required for Lyn-dependent
LMP2A degradation.
In the next series of experiments, Lyn expression was analyzed
similarly. The reduction of Lyn was observed when c-Cbl was
coexpressed (Fig. 3A, Lyn, compare lanes 1, 4, 8, and 11 with lanes 5,
7, 12, and 14). The Lyn reduction was not observed when the c-Cbl
RING-ﬁnger mutant 70Z was coexpressed instead of wild type c-Cbl
(Fig. 3B, Lyn, compare lane 15 with lane 16, lane 19 with lane 20, lane
21 with lane 22, and lane 25 with lane 26). Thus, Lyn levels are, at least
in part, regulated by the RING-ﬁnger ubiquitin ligase activity of c-Cbl.
However, neither LMP2A nor Syk changed the c-Cbl-mediated Lyn
degradation (Fig. 3A, Lyn, compare lane 5 with lanes 7 and 12).
Moreover, neither the Y112F nor the Y74/85F LMP2A mutants altered
Lyn degradation (Fig. 3C, Lyn, lanes 31, 36 and 41). Previous studies
have shown that both the Y112F mutant and the Y74/85F mutant are
non-functional in B cells (Fruehling et al., 1998). The Y112F mutant is
unable to bind Lyn whereas the Y74/85F which has a mutated ITAM
does not bind Syk (Fruehling and Longnecker, 1997; Fruehling et al.,
1998). This indicates that the Lyn degradation by c-Cbl was
independent of LMP2A or LMP2A signalosome formation.
Finally, Syk levels were analyzed in the transfected cells. Although
the c-Cbl-mediated reduction was similarly observed for Syk, Syk
reductionwas dependent on LMP2A in contrast to Lyn (Fig. 3A). The Syk
reductionwas relatively small when only c-Cbl was coexpressed, but in
the presence of LMP2A coexpression with c-Cbl dramatically reduced
Syk levels (Fig. 3A, Syk, lanes 2, 6 and 13). In addition to LMP2A
coexpression, the additional coexpression of Lyn with LMP2A further-
more diminished this Syk reduction (Fig. 3A, Syk, compare lane6with7
and lane 13 with lane 14). Moreover, the 70Z mutant restored the Syk
levels in the presence of LMP2A although it did not in the absence of
LMP2A (Fig. 3B, Syk, lanes 17–18 and 23–24). Thus, c-Cbl degrades Syk
efﬁciently in the presence of LMP2A. In the absence of LMP2A, Lyn can
modestly reduce Syk (Fig. 3A, Syk, lanes 2 and 4). This Lyn alteration on
Syk expression was independent of the c-Cbl RING since the 70Z-Cbl
did not restore the Syk expression (Fig. 3B, Syk, lanes 19 and 20). The
mechanism of the latter observation remains to be elucidated.
Phosphorylation of LMP2A, Lyn, Syk, and c-Cbl
Since phosphorylation is critical for the formation of most
receptor-mediated signalosomes, we examined the phosphorylation
of LMP2A, Lyn, Syk and Cbl. In the absence of Lyn and Syk, LMP2A
phosphorylation was negligible, indicating the key roles of these two
proteins in LMP2A phosphorylation. Interestingly, Lyn or Syk was
sufﬁcient for LMP2A phosphorylation (Fig. 3A, pLMP2A, lanes 8 and 9)
indicating that high levels of Syk expression can bypass the previously
observed requirement for Lyn for the initial steps in LMP2A
phosphorylation (Fruehling et al., 1998). As might be expected, the
combination of both Lyn and Syk produced the highest levels of
LMP2A phosphorylation (Fig. 3A, pLMP2A, lane 11). LMP2A binds to
Lyn through phosphorylated Y112 while it binds to Syk through
phosphorylated Y74 and Y85 of the LMP2A ITAM (Fruehling and
Longnecker, 1997; Fruehling et al., 1998). As shown in Fig. 3C, the
Y112F mutation in LMP2A caused the loss of LMP2A phosphorylation
by Lyn (pLMP2A, compare lane 28 with lane 33), however it did not
affect LMP2A phosphorylation mediated by Syk (pLMP2A, compare
lane 29 with lane 34). Thus, Y112 is not only required for the
interaction with Lyn but also essential for LMP2A phosphorylation
mediated by Lyn. Although not as dramatic as observed for the Y112F
mutation and Lyn, the Y74/85F mutation greatly reduced LMP2A
Fig. 3. Expression and phosphorylation of LMP2A, Lyn, Syk and c-Cbl. CHO-K1 cells were transfectedwith 1 μg of wild type (WT) ormutant LMP2A-HA, Lyn, Syk-Myc, andwild type (WT) ormutant c-Cbl-Flag (70Z) as indicated. Cell lysates were
immunoblotted with anti-LMP2A, Lyn, Syk or c-Cbl antibody to detect both endogenous and transfected expression. Immunoprecipates of LMP2A (HA), Lyn, Syk (Myc) and c-Cbl (Flag) were immunoblotted for phosphotyrosine. The data is the
representative of three comparable experiments.
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Fig. 5. LMP2A-dependent Syk degradation by c-Cbl. (A) CHO-K1 cells were transfected
with indicated amount of LMP2A-HA,1 μg of Syk-Myc, and 1 μg of c-Cbl-Flag. Cell lysates
were immunoblotted for LMP2A, Syk and c-Cbl. (B) CHO-K1 cells were transfected with
1 μg of wild type or ITAM-mutant LMP2A-HA, Syk-Myc, c-Cbl-Flag and Ub-His. Anti-Syk
(Myc) immunoprecipitates were immunoblotted with anti-His antibody to detect
ubiquitin-conjugated Syk. The data is the representative of three comparable
experiments.
Fig. 4. Lyn degradation by c-Cbl RING. (A) CHO-K1 cells were transfectedwith 1 μg of Lyn
and indicated amount of c-Cbl-Flag. Cell lysates were immunoblotted for Lyn and c-Cbl.
(B) CHO-K1 cells were transfected with Lyn, wild type or mutant c-Cbl-Flag, and Ub-His.
Lyn immunoprecipitates were immunoblotted with anti-His antibody to detect
ubiquitin-conjugated Lyn. (C) Transfected CHO-K1 cells were treated with 10 μM
MG132 and immunoblotted for Lyn and c-Cbl. The data is the representative of three
comparable experiments.
187M. Ikeda, R. Longnecker / Virology 385 (2009) 183–191phosphorylation by Syk (Fig. 3C, pLMP2A, compare lane 29 with lane
39), while the phosphorylation mediated by Lyn transfection was
fairly similar to wild type LMP2A (Fig. 3C, pLMP2A compare lane 28
with lane 38). This emphasizes the necessity of the LMP2A ITAM for
high level LMP2A phosphorylation.
In addition to phosphorylating LMP2A, Lyn transfection resulted in
the phosphorylation of Syk, c-Cbl and Lyn (Fig. 3A, pSyk lane 4, pCbl
lane 5, and pLyn lane 1). Syk expression resulted in the phosphoryla-
tion of c-Cbl as well as Syk phosphorylation (Fig. 3A, pCbl lane 6, pSyk
lane 2). These results indicate, as might be expected that Lyn and Syk
have differences in substrate speciﬁcity. As shown in Fig. 3A, in the
presence of Lyn, Syk phosphorylationwas increased (pSyk lanes 2 and
4), however in the presence of Syk, Lyn phosphorylation was not
increased (pLyn lanes 1 and 4). In regard to the requirement of LMP2A
for the observed phosphorylation, Lyn phosphorylation was indepen-
dent of LMP2A (Fig. 3A, pLyn, lanes 1 and 8), whereas Lyn- and Syk-
mediated Syk phosphorylation was considerably increased when
LMP2A was present (Fig. 3A, pSyk, lanes 2 and 9). Moreover, c-Cbl
phosphorylation in the presence of Syk was signiﬁcantly enhanced by
LMP2A (Fig. 3A, pCbl, lanes 6 and 13). These observations may indicate
that the action of Lyn is an early requirement for the LMP2Asignalosome formation as our earlier studies have suggested (Fruehl-
ing et al., 1998).
c-Cbl RING mediates Lyn degradation
The molecular mechanism of Lyn degradation by c-Cbl was further
examined. As shown in Fig. 3A, transfection of only c-Cbl was sufﬁcient
to degrade Lyn. This was veriﬁed by demonstrating a dose-dependent
decrease in Lyn expression by reducing the amount of c-Cbl cotrans-
fectedwith Lyn (Fig. 4A).We next testedwhether Lynwas ubiquitinated
by the c-Cbl E3activity. As shown inFig. 4B, Lynwashighlyubiquitinated
without c-Cbl overexpression, but the levels of Lyn were not as greatly
reduced aswhen c-Cblwas transfected. The Lynubiquitination observed
in the absence of c-Cbl is likely mediated by ubiquitin ligases
constitutively expressed in the CHO-K1 cells. To further investigate
these observations, the c-Cbl 70Zmutant was expressed instead of wild
type c-Cbl. Expression of this c-Cbl mutant increased the amount of Lyn
and the ubiquitination as observed in the cells transfected with just Lyn
(Fig. 4B, lane 4). This results are quite interestingly and suggest that
188 M. Ikeda, R. Longnecker / Virology 385 (2009) 183–191overexpression of the c-Cbl mutant mediates more efﬁcient Lyn
degradation. This may be explained by the c-Cbl adapter ability, in
whichboth LynandNedd4-family E3s are recruitedbyc-Cbl, causing the
degradation of Lyn by the Nedd4-family. Finally, we addressed the
question whether the Lyn degradation is mediated by proteasomes. As
shown in Fig. 4C, the proteasome inhibitor MG132 resulted in a modest
increase in Lyn levels, indicating that a portion of Lyn is processed in
proteasome. However, since there was not a complete restoration other
mechanisms may be involved in the Lyn degradation and/or the
inhibition of the proteoseome by MG132 may not be complete.
c-Cbl mediates LMP2A-dependent Syk degradation
The role of LMP2A in Syk degradation was further analyzed in
transfection by increasing the amount of LMP2A included in the
transfection with c-Cbl and Syk. A dose-dependent increase in Syk
degradation was observed when more LMP2A was included in the
transfection (Fig. 5A). The amount of LMP2A-catalyzed Syk degrada-
tion correlated with increased Syk ubiquitination (Fig. 5B, lanes 3 and
4). In contrast to Lyn, Syk was not constitutively ubiquitinated even
when c-Cbl was overexpressed (compare Fig. 5B, lanes 2 and 3 with
Fig. 4B, lanes 2 and 3). Syk ubiquitination was only observed in the
presence of LMP2A (Fig. 5B, lanes 2 and 4). Interestingly, Syk
degradation did not appear to be dependent on c-Cbl since transfec-
tion of the c-Cbl mutant 70Z had no effect on Syk levels or Syk
ubiquitination (Fig. 5B, lanes 4 and 6). Finally, by using the LMP2AY74/
85F ITAM mutant that does not bind Syk, it was apparent that the
interaction of Syk with LMP2A is required for the LMP2A-mediated
degradation of Syk (Fig. 5B, lanes 5 and 7).
Nedd4-family ubiquitin ligases are not required for Lyn-mediated LMP2A
degradation
In our ﬁnal series of experiments, we investigated the mechanism
of Lyn-mediated degradation of LMP2A. The interaction between c-CblFig. 6. Lyn-mediated LMP2A ubiquitination. (A) CHO-K1 cells were transfected with 1 μg of LM
Lyn. (B) CHO-K1 cells were transfected with LMP2A-HA, Lyn, and Ub-His. HA immunoprecip
(C) CHO-K1 cells were transfected with wild type or PY1PY2 mutant LMP2A-HA, and Lyn. Ce
with LMP2A-HA, Lyn, and wild type (WT) or mutant AIP4 (C814A). Cell lysates were immuno
experiments.and Lyn (Kaabeche et al., 2004) raises the possibility that LMP2A
recruits c-Cbl to degrade the LMP2A signalosome by using Lyn as an
adaptor protein. Indeed, Lyn increased LMP2A degradation as well as
ubiquitination (Figs. 6A and B). To verify this model, the effect of the c-
Cbl 70Z mutation on LMP2A degradation was tested. As shown in Fig.
3B, the c-Cbl 70Z mutation inhibited Lyn degradation (Lyn, compare
lane 15 with lane 16, lane 19 with lane 20, lane 21 with lane 22, and
lane 25 with lane 26), however the c-Cbl mutant did not increase
LMP2A degradation (LMP2A, compare lane 21 with lane 22, lane 23
with lane 24, and lane 25 with lane 26). Instead, it appeared that
increased Lyn expression resulted in a decrease of LMP2A (Fig. 3B,
LMP2A, lanes 22 and 26). Thus in this experiment, c-Cbl seemed to
inhibit the negative regulator role of Lyn in LMP2A expression. In
addition, our data suggests that the Lyn interaction with LMP2A is
unnecessary for Lyn-dependent LMP2A degradation. As shown in Fig.
3C, the Lyn-binding deﬁcient LMP2A mutant Y112F in which the
LMP2A tyrosine that binds Lyn is mutated or the Syk-binding deﬁcient
Y74/85F mutant in which the LMP2A ITAM that binds Syk has been
mutated, still demonstrate Lyn-dependent LMP2A degradation
(LMP2A, lanes 28, 33 and 38). Thus, the exact molecular mechanism
that Lyn utilizes to promote LMP2A degradation is not clear. Despite
these observations, the signiﬁcant increase in LMP2A degradation and
ubiquitination by Lyn indicate the involvement of ubiquitin ligases in
Lyn-mediated LMP2A degradation. Previous studies have shown that
LMP2A is ubiquitinated by Nedd4-family E3s and that Src-family PTKs
interact with Nedd4-family E3s, suggesting that Lyn increases the
Nedd4 E3 activity by stabilizing the Nedd4 interaction with LMP2A.
However, the Nedd4-interaction deﬁcient PY1PY2 mutation within
LMP2A does not reduce Lyn-mediated LMP2A degradation (Fig. 6C,
lane 4). This indicates that Nedd4 E3s have little role in Lyn-mediated
LMP2A degradation. Instead, Nedd4 E3s likely degrade LMP2A in
addition to the enhancement of LMP2A degradation observed when
Lyn is transfected. As shown in Fig. 6D, the Nedd4-family member
AIP4/Itch induced LMP2A degradation when coexpressed with Lyn
(LMP2A, lanes 4 and 7). Interestingly, the degradation of AIP4/Itch likeP2A-HA and indicated amount of Lyn. Cell lysates were immunoblotted for LMP2A and
itate was immunoblotted with anti-His antibody to detect ubiquitin-conjugated LMP2A.
ll lysates were immunoblotted for LMP2A and Lyn. (D, E) CHO-K1 cells were transfected
blotted for LMP2A, Lyn and AIP4/Itch. The data is the representative of three comparable
Fig. 7. Schematic model for the speciﬁc degradation and phosphorylation of LMP2A
signalosome. The LMP2A signalsome consists of a large complex mediated by a variety
of protein–protein and phosphotyrosine–SH2 interactions (indicated by dotted lines in
both Panels A and B). By forming a signalosome, LMP2A manipulates normal BCR
signaling by targeting proteins in the LMP2A signalosome for degradation (indicated by
arrows in panel A) and/or phosphorylation (indicated by arrows in panel B). (A) c-Cbl
and Nedd4-family E3s respectively target speciﬁc proteins recruited to the LMP2A
signalosome. Syk is speciﬁcally degraded as a result of constitutive LMP2A tyrosine
phosphorylation mediated by the Lyn and Syk PTKs resulting in the phosphorylation
and recruitment of c-Cbl to the LMP2A signalsome. This recruitment results in the
degradation of Syk by c-Cbl. Thus, LMP2A and LMP2A phosphorylation are critical for
the Syk degradation by c-Cbl. c-Cbl is also capable of degrading Lyn, however, LMP2A is
unnecessary for this degradation. In contrast, Lyn is speciﬁcally downregulated by
Nedd4-family ubiquitin ligases in the presence of LMP2A. Thus, the two key tyrosine
kinases Lyn and Syk in LMP2A signaling are downregulated by two different ubiquitin
ligases. In addition, although LMP2A is degraded by Nedd4-family ubiquitin ligases, we
show in this study that Lyn enhances LMP2A degradation. Although the exact
mechanism is unknown, our previous results indicate that lipid raft-mediated
endocytosis may be key (Ikeda and Longnecker, 2007). (B) Lyn is able to induce the
activation and phosphorylation of a number of substrate proteins independent of
LMP2A including Lyn, c-Cbl, and LMP2A. In contrast, the activation of Syk by Lyn is
dependent on LMP2A. Interestingly, the activation and phosphorylation of c-Cbl by Syk
is independent of LMP2A whereas the activation and phosphorylation of Syk is
dependent on LMP2A. The observations are of interest since they indicate a remarkable
degree of speciﬁcity of the tyrosine kinases that are recruited to the LMP2A signalsome
for targeting proteins contained within the LMP2A signalosome.
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transfections inwhich LMP2A is omitted (Fig. 6D, AIP4, compare lane 3
with lane 5, and lane 6 with lane 7). The HECT-domain mutation
C814A within AIP4 was not sufﬁcient to restore LMP2A expression to
the level without Lyn coexpression (Fig. 6E, LMP2A, lanes 1, 3, 5 and 7).
Thus, dominant-negative AIP4 did not suppress Lyn-mediate LMP2A
degradation suggesting that both Lyn and Nedd4 regulate LMP2A
levels in parallel.
Discussion
LMP2A development and survival signals are critical for the
establishment of EBV latent infections and EBV-related malignant
transformation. However, the molecular basis of LMP2A signaling and
its regulation are not well understood. Here, we show that c-Cbl E3
downregulates the LMP2A signalsome and LMP2A induction of the
viral lytic cycle. The Cbl-family proteins play a critical role in
negatively regulating signals from BCR. Therefore, the involvement
of c-Cbl in LMP2A signaling is not unexpected since LMP2A in many
ways mimics a functional BCR. We demonstrated in this study that c-
Cbl reduced Lyn expression in a LMP2A-independent manner while c-
Cbl induced Syk degradation only in the presence of LMP2A. Thus, c-
Cbl speciﬁcally downregulates Syk levels in the presence of LMP2A.
This may be particular important for signals that emanate from
LMP2A signalosome since this signal does not fully resemble an
activated BCR (Portis and Longnecker, 2004a). In contrast to the
dependence of c-Cbl to downregulate Syk levels, our earlier studies
demonstrated Lyn speciﬁc degradation in LMP2A expressing cells is
mediated by the Nedd4-family E3s. Taken together, these results
allow us to propose a model in which c-Cbl and Nedd4-family
ubiqutin ligases cooperate to degrade LMP2A target proteins at
discrete steps in the function of the LMP2A signalosome (Fig. 7A).
Nedd4-family E3s speciﬁcally degrade Lyn in the initiation of LMP2A
signaling while c-Cbl strictly targets Syk as the LMP2A signalosome
signal expands to target additional proteins which have been
identiﬁed such as Btk, PI3Kinase, Akt, NF-kB, and Ras (Merchant
and Longnecker, 2001; Portis and Longnecker, 2004b; Scholle et al.,
2000; Swanson-Mungerson et al., 2005; Wang et al., 2006). This
downmodulation of the LMP2A signalosome by c-Cbl and Nedd4
family E3s may be in particularly important in regulating the strength
of the LMP2A signal. Future studies will focus on the importance of
the ubiquitin ligases for the regulation of downstream targets of the
LMP2A signalosome.
In addition to the importance of c-Cbl E3 activity, many cellular
events mediated by c-Cbl are dependent on c-Cbl adapter function.
c-Cbl has been shown to form complexes with numerous proteins via
its various binding domains. Our results indicate a potential
importance of c-Cbl adapter function in LMP2A signalosome function.
For example, the LMP2AY74/85Fmutant is deﬁcient in Syk association
and only Lyn and not Syk is able to bind this LMP2Amutant. However,
when Syk is expressed along with Lyn, there is an increase in the
phosphorylation of Y74/85F mutant. This indicates that Syk is able to
recognize this LMP2A mutant through an interaction independent of
binding of the tandem Syk SH2 domains with the LMP2A ITAM
comprised of LMP2A Y74 and Y85. Since it is has been previously
shown that c-Cbl interacts with Src-family protein tyrosine kinases
and Nedd4-family ubiquitin ligases (Andoniou et al., 2000; Courbard
et al., 2002; Kaabeche et al., 2004; Magniﬁco et al., 2003; Rao et al.,
2002; Sanjay et al., 2001), it is reasonable to speculate that the
interaction of c-Cbl with either Lyn or Nedd4 ubiquitin ligase enables
Syk to interact with LMP2A and mediate the observed phosphoryla-
tion (Fig. 7B). Our attempts to detect a direct or indirect c-Cbl
interaction with LMP2A by immunoprecipitation failed (data not
shown). This suggests that the LMP2A interactionwith c-Cbl is weaker
than the interaction of LMP2A with Lyn, Syk, or Nedd4-family
ubiquitin ligases. Additionally, detergent-sensitive cellular structuressuch as lipid rafts may provide a platform to recruit LMP2A and c-Cbl
for their subsequent and continued interaction.
In addition to the factors such as c-Cbl that regulate the LMP2A
signalosome, we made the interesting observation that expression of
Lyn can also induce LMP2A degradation. Although our results suggest
that this degradation was directed by c-Cbl, our recent studies on
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and Longnecker, 2007). Previously, we demonstrated that cholesterol
depletion from plasma membrane dramatically increases LMP2A
abundance (Ikeda and Longnecker, 2007). In these studies, we
hypothesized that this was a result of blocking endocytosis of the
LMP2A signalosome. The cholesterol depletion also blocked LMP2A
phosphorylation and ubiquitination. As Lyn and LMP2A are constitu-
tively present in lipid rafts (Dykstra et al., 2001), the block of LMP2A
phosphorylation by cholesterol depletion can be explained by the
disruption of lipid rafts and the resulting dissociation of LMP2A and
Lyn. The increase of LMP2A ubiquitination by Lyn observed in this
study correlates nicely with our previous study. Therefore, it may be
reasonable to conclude that the interaction of Lyn with LMP2A
promotes endocytosis of the LMP2A signalosome.
Overall, the results presented in this study provide new informa-
tion into formation of the LMP2A signalosome and subsequent
regulation of signals that are transduced by LMP2A.
Materials and methods
Cell culture
All cell lines were maintained in medium supplemented with 10%
serum, 100 U/ml penicillin and 100 μg/ml streptomycin. RPMI1640
medium was used for the culture of B cell lines. LCL1 is a B95-8 EBV-
transformed lymphoblastoid cell line (LCL) expressing wild-type
LMP2A (Longnecker and Kieff, 1990). ES1 is a LCL harboring LMP2A-
deleted EBV genome (Longnecker et al., 1993). BJAB is an EBV negative
B lymphoma cell line obtained from ATCC (Rockville, MD). The BJAB
cell line expressing LMP2A (BJAB-LMP2A+) was previously described
(Longnecker and Kieff, 1990). EREB2.5 is an estrogen-dependent LCL
and grown in medium with 1 μM estrogen and was kindly provided
by Bettina Kempkes. Chinese hamster ovary (CHO)-K1 cells were
grown in Ham's F12 medium. Human Embryonic Kidney (HEK) 293T
cells were grown in DMEM.
Antibodies
The anti-LMP2A rat monoclonal antibody (14B7) was previously
described (Fruehling et al., 1996). The anti-HA mouse monoclonal
antibody (12CA5) was from Covance. The anti-Mycmousemonoclonal
antibody (9E11) was puriﬁed at the Northwestern University Mono-
clonal Antibody Facility. The anti-Flag mouse monoclonal antibody
(M2) was from Sigma. The anti-Lyn, Syk, and Cbl rabbit polyclonal
antibodies were from Santa Cruz. The anti-GAPDHmouse monoclonal
antibody was from Abcam. The anti-phosphotyrosine mouse mono-
clonal antibody (PY20) was from Santa Cruz. The anti-BZLF1 mouse
monoclonal antibodywas described previously (Young et al., 1991). All
horseradish peroxidase (HRP)-conjugated secondary antibodies were
purchased from Amersham.
Plasmids
The wild type or HA-tagged LMP2A cDNA was subcloned in the
mammal expression vector pSG5 (Fruehling et al., 1998). The LMP2A
mutant constructs of Y112F, Y74/85F, and PY1PY2 were described
previously (Fruehling and Longnecker, 1997; Fruehling et al., 1998;
Ikeda et al., 2001). The Lyn cDNAwas ampliﬁed by PCR frompSV7c-Lyn
and subcloned intopcDNA3.1Neo.Myc-tagged Sykexpressionplasmid,
cloned in pcDNA3.1 Neo, was obtained from Dr. S. Latour (Latour et al.,
1996). The wild type c-Cbl and oncogenic mutant 70Z cDNAs, obtained
from Dr. Y. Yarden, were Flag-tagged by PCR ampliﬁcation and
subcloned into pcDNA3.1 Neo. The His-tagged ubiquitin expression
plasmid was obtained from Dr. D. Bohmann. The Flag-tagged AIP4 and
C814Amutant plasmids were described previously (Ikeda et al., 2000).
The Gag–Pol expression plasmid psPAX2 was obtained from Addgene.The VSV-G expression plasmid pVSV-G was purchased from Clontech.
The Cbl shRNAmir (V2LHS 48407) and none-silencing shRNAmir
(RHS4346) cloned in pGIPZ lentiviral vector were purchased from
Open Biosystems (Huntsville, AL). The region from −221 to +12 of
BZLF1 promoter (Zp)was PCR ampliﬁed and cloned into the pGL3 Basic
plasmid (Promega) as a SacI/BglII fragment.
Transfection
CHO-K1 cells were transfected by using Lipofectamine 2000
(GIBCO/BRL). 70% conﬂuent CHO-K1 cells in 6-well plate were
incubated with DNA in lipid micelles for 6 h and were analyzed
after 18 h. BJAB cell lines and LCLs were electroporated with DNA by
using Amaxa nucleofector II (Amaxa). A total of 5×106 cells were
electroporated with the solution C and the program X-001 and were
analyzed after 24 h.
Packaging and infection of shRNA lentiviruses
For packaging lentiviruses, 293T cells were transfected with 12 μg
of pGIPZ shRNAmir, 6 μg of psPAX2, and 0.375 μg of pVSV-G plasmids
by using Lipofectamine 2000. Following four-hour incubation, the
media of transfected cells were replaced with fresh media and
cultured for additional 24 h. Produced lentiviruses were prepared by
ﬁltrating the culture and stored with 4 μg/ml polybrene as stocks. For
lentiviral infection, cells were incubated with the viral stock for 24 h
and then cultured in the complete medium. Infected cells were
selected with 400 μg/ml puromycin and used for further analysis.
Luciferase assays
BJAB cells were transfected with Gene Pulser (Bio-Rad) at 210 V
and 960 μF. Twenty-four hours post-transfection, cells were washed
with sterile PBS and lysed with passive lysis buffer (Promega) for 30-
min with rocking. Relative luciferase activity was measured with the
Promega Luciferase Reporter Assay System in a Visibottom 96-well
plate using a Victor plate reader according to the kit instructions.
Immunoprecipitation
A total of 1×107 cells were harvested and lysed in 1 ml of Triton X-
100 lysis buffer (50 mM Tris–HCl pH 7.5, 150 mM NaCl, 1% Triton X-
100, 10% glycerol, 10 mM NaF, 1 mM Na3VO4, 2 mM EDTA, 0.5 mM
phenylmethylsulfonyl ﬂuoride, 10 μg/ml pepstatin, 10 μg/ml leupep-
tin). Cleared lysates were incubated with the appropriate antibody for
1 h at 4 °C. Immune complexes were captured with 20 μl of Protein A
or G-Sepharose (Pharmacia) for 1 h at 4 °C. Following three washes
with lysis buffer, immunoprecipitated proteins were re-suspended in
2× SDS-PAGE sample buffer.
Immunoblotting
Protein samples were resolved by SDS-PAGE, transferred to
Immobilon, and blocked with 4% skim milk or 4% bovine serum
albumin (BSA) in TBST (10 mM Tris–HCl pH 7.5, 150 mM NaCl, 0.05%
Tween 20) at room temperature for 1 h. Membranes were then
incubated in 4% skimmilk or 4% BSA in TBSTwith primary antibody for
1 h, and then with appropriate secondary antibody for 1 h. Following
incubation, the membranes were washed with TBST, and the blot was
visualized using ECL (Amersham).
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